A Study to Assess the Efficacy and Safety of RO7790121 for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This Phase III, multicenter, double-blind, placebo-controlled, treat-through study will evaluate the efficacy and safety of RO7790121 compared with placebo in participants with moderately to severely active ulcerative colitis (UC).
Epistemonikos ID: c5c74df3e1480748c7827892e319c91cbe5dd144
First added on: Oct 01, 2024